Drug: NEVIRAPINE. Injury: Lipodystrophy acquired Quarter: 2016Q3
Total Records: 6 Number of Pages: 1
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 71171719 | NEVIRAPINE. | Lipodystrophy acquired | BRISTOL MYERS SQUIBB | 52.00 YR | M | 0 | 20160922 | US |
| 119071002 | NEVIRAPINE. | Lipodystrophy acquired | BRISTOL MYERS SQUIBB | 36.90 YR | F | 61 KG | 20160826 | GB |
| 119141462 | NEVIRAPINE. | Lipodystrophy acquired | BRISTOL MYERS SQUIBB | 34.62 YR | F | 68 KG | 20160826 | GB |
| 119248362 | NEVIRAPINE. | Lipodystrophy acquired | VIIV | 36.00 YR | F | 61 KG | 20160906 | GB |
| 126434631 | NEVIRAPINE. | Lipodystrophy acquired | ROCHE | 54.00 YR | M | 0 | 20160811 | CA |
| 730262226 | NEVIRAPINE. | Lipodystrophy acquired | MERCK | 52.00 YR | M | 0 | 20160923 | US |
Total Records: 6 Number of Pages: 1